Lupin Limited has informed the Exchange regarding a press release dated March 20, 2023, titled "Lupin s Alliance Partner Caplin Receives U.S. FDA Approval for Rocuronium BromideInjection.".
Lupin Limited has informed the Exchange regarding a press release dated March 20, 2023, titled "Lupin s Alliance Partner Caplin Receives U.S. FDA Approval for Rocuronium BromideInjection.".